2 ms·
They ran a clinical trial where they accidentally gave a number of patients half a dose. Apparently this was due to lack of validation of an assay by Oxford.
by refurb 6y ago
They ran a clinical trial where they accidentally gave a number of patients half a dose. Apparently this was due to lack of validation of an assay by Oxford.
I think the problem is that these "small" issues pop up which just further erodes confidence in the vaccine.
- Wildgoose 6y agoAnd yet that accident enabled them to discover that an initial "half" dose eas actually more successful than an initial "full" dose. All of this has been very well scrutinised and documented, far more so than any other vaccine supplier.